Stingl, J.C.

patient stroke atrial fibrillation study anticoagulation coumarin anticoagulant –effectivenes warfarin fibrillation atrial country cost –effectiveness percentage time treatment range therapy health anticoagulant care european countries genotyping university netherland monitoring dosing clinic trial coumarin derivatives measurement percentage group anticoagulant therapy review 100  patient-years management austria science complication pharmacogenetic difference european cost –effectiveness analyses future sweden target hospital event target inr range germany quality acenocoumarol dabigatran 100  utrecht inr measurement cyp 2c patient-year phenprocoumon inr measurements effectiveness self-management greece anticoagulation clinics anticoagulant treatment inr monitoring prevalence pharmacogenomic analyses derivative healthcare van schie ana ­ysis utrecht university eu-pact pharmacogenetic-guided dosing nonvalvular atrial fibrillation organization ischemic schie vkorc